Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
about
Stem cell therapy for chronic ischaemic heart disease and congestive heart failureStem celltherapy for ischemic heart failureInhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem CellsStem Cell Imaging: Tools to Improve Cell Delivery and Viability.Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart DiseaseAre Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and PerspectivesTransmyocardial revascularization devices: technology updateStem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applicationsStem cell therapy for chronic heart failure: an updated appraisalCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsCurrent stem cell delivery methods for myocardial repairBone marrow mononuclear cells and acute myocardial infarctionImaging: guiding the clinical translation of cardiac stem cell therapyWidespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and HistologyCell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffoldBone marrow stem cell transplantation for cardiac repairMesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular ApplicationsStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Cell therapy for cardiac repair--lessons from clinical trials.Systems biology of pro-angiogenic therapies targeting the VEGF systemTracking of stem cells in vivo for cardiovascular applications.Molecular Imaging of Stem Cell Transplantation in Myocardial Disease.Cardiovascular therapeutic uses of targeted ultrasound contrast agents.X-ray fused with magnetic resonance imaging (XFM) to target endomyocardial injections: validation in a swine model of myocardial infarction.Combined intermittent hypoxia and surface muscle electrostimulation as a method to increase peripheral blood progenitor cell concentration.Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesionThe use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty.Angiogenic therapy for coronary artery and peripheral arterial disease.Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure A Systematic Review of the Existing Data and Ongoing Trials.Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment.Bone marrow cells for cardiac regeneration and repair: current status and issues.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.Cell therapy in congestive heart failure.Intracoronary autologous bone marrow-derived mononuclear cell transplantation improves coronary collateral vessel formation and recruitment capacity in patients with ischemic cardiomyopathy: a combined hemodynamic and scintigraphic approach.Cardiac repair with adult bone marrow-derived cells: the clinical evidence.Heart failure management: the present and the future.Unchain my heart: the scientific foundations of cardiac repairEarly increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.Morphological and functional changes in bone marrow mesenchymal stem cells in rats with heart failure.Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease
P2860
Q24194988-AE17F740-7C74-44B1-9194-34DEF33CC4BCQ24537182-0880A96B-3613-470F-B201-8A17179B1B92Q26747038-307BAA9C-170B-49F4-AF78-6C155BF718A2Q26765843-E58263E7-1E83-4E3D-8C66-903A2B34694FQ26774781-F776BF13-9D94-4940-842F-35450DBBE21EQ26778217-945BBBB7-629F-423D-B411-E23EFF848183Q26865489-A72B8F7F-6B3C-4DB2-90A5-F8FAE67B4A35Q26865849-923C4DF3-8B5F-44D0-9C97-7E3FFEA297B1Q26866170-5411DFF7-3979-45E0-B5BD-DF01FEA0F9B7Q27001159-1A0C1215-6CC8-4F7B-8706-17167B8D4F7BQ27004753-6AD5B693-8054-4A98-9C58-BBA836622435Q27006710-B8BF6A7D-379D-4442-8EAC-8EDC3B7552DEQ27008410-E64852D4-26F8-496B-AD40-7A8EF57DBBD9Q27335541-F957B13A-D5A4-4EFE-A7AA-CBE72832A394Q27347330-A43F6F55-CA9B-4518-A01D-98E3DCB58601Q28251098-1ABF455A-D14A-475F-967B-0B2ADF0D9F1BQ28551325-8644E409-BDB7-4ACB-A67B-A2D5E65B6ED2Q30239945-12A9884A-3923-4A8D-938E-DC7321E6197FQ30359782-05F53263-82CE-4E63-8F4F-616682AAEB22Q30430112-9800AB39-DB0D-4E20-A64A-AAA027F1409FQ30443013-3026ECE7-280B-4F13-947E-D036A986C658Q30477168-ED87224D-5D6D-4F31-BDEA-0DD8CC5062E7Q30479697-EBBCF9FC-E77E-4760-917D-0055284045A6Q30480221-EC38974F-30ED-4A81-B386-412FA50A2C4BQ30491515-402B5B3D-E7CD-4A39-84B2-B6009A072E20Q30541317-548B2203-A121-4407-93BF-1AFD744BB268Q30567453-C0B31F09-1E9C-44EF-A9AD-406675479A23Q30783593-93943063-1DDD-423C-8449-C2E40AC17582Q31110980-E1A4ABC9-ECDD-4A28-B9EF-EC0F39498D3BQ33225563-A6273F5B-4BCC-41D7-9569-238FA86FAB8EQ33254416-07727281-9288-49D5-85C5-DE50D57CA192Q33257976-395DC3B8-8D71-407F-B587-292CE1002B9CQ33295408-5140A558-4057-4811-B8D5-EECE8F9A7F35Q33327638-07DDC0C4-C897-4F64-B7F3-50C4EB43DA5BQ33406980-7ABAC900-772F-40E3-8B96-CA50F8567164Q33605156-8508F4AF-B5C1-4107-BFBC-14E0F8E03F0DQ33683767-7B9683E4-3BF1-4193-9CA5-15179A45E623Q33742308-9FC1E833-47ED-4713-9C6F-062CAEAAD4F3Q33744464-8A465A12-D438-4919-8AE7-A1364F33D303Q33753521-545031B3-9012-4D24-B8D8-AA0504506B4C
P2860
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Transendocardial, autologous b ...... hronic ischemic heart failure.
@en
Transendocardial, autologous b ...... hronic ischemic heart failure.
@nl
type
label
Transendocardial, autologous b ...... hronic ischemic heart failure.
@en
Transendocardial, autologous b ...... hronic ischemic heart failure.
@nl
prefLabel
Transendocardial, autologous b ...... hronic ischemic heart failure.
@en
Transendocardial, autologous b ...... hronic ischemic heart failure.
@nl
P2093
P1433
P1476
Transendocardial, autologous b ...... hronic ischemic heart failure.
@en
P2093
Andre L S Sousa
Antonio C Carvalho
Claudio T Mesquita
Emerson C Perin
Evandro T Mesquita
Fernando O D Rangel
Guilherme V Silva
Hans F R Dohmann
Hans J F Dohmann
Helio S Dutra
P304
P356
10.1161/01.CIR.0000070596.30552.8B
P407
P577
2003-04-21T00:00:00Z